3D In Vitro Technology for Drug Discovery

被引:16
|
作者
Hosseinkhani, Hossein [1 ]
机构
[1] Natl Taiwan Univ Sci & Technol, Grad Inst Biomed Engn, Taipei 10607, Taiwan
关键词
3D scaffold; toxicity testing in vitro; replacement alternative; hydrogel; biochip;
D O I
10.2174/157488612800492753
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Three-dimensional (3D) in vitro systems that can mimic organ and tissue structure and function in vivo, will be of great benefit for a variety of biological applications from basic biology to toxicity testing and drug discovery. There have been several attempts to generate 3D tissue models but most of these models require costly equipment, and the most serious disadvantage in them is that they are too far from the mature human organs in vivo. Because of these problems, research and development in drug discovery, toxicity testing and biotech industries are highly expensive, and involve sacrifice of countless animals and it takes several years to bring a single drug/product to the market or to find the toxicity or otherwise of chemical entities. Our group has been actively working on several alternative models by merging biomaterials science, nanotechnology and biological principles to generate 3D in vitro living organs, to be called "Human Organs-on-Chip", to mimic natural organ/tissues, in order to reduce animal testing and clinical trials. We have fabricated a novel type of mechanically and biologically bio-mimicking collagen-based hydrogel that would provide for interconnected mini-wells in which 3D cell/organ culture of human samples in a manner similar to human organs with extracellular matrix (ECM) molecules would be possible. These products mimic the physical, chemical, and biological properties of natural organs and tissues at different scales. This paper will review the outcome of our several experiments so far in this direction and the future perspectives.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 50 条
  • [21] Platform for drug discovery by grid technology: Large scale molecular calculations and utilization of 3D descriptors.
    Chuman, H
    Nagashima, U
    Nishikawa, T
    Ito, M
    Goto, H
    Nakayama, N
    Boku, T
    Sato, M
    Feng, C
    Inagaki, Y
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U301 - U301
  • [22] Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment based drug discovery
    Morrison, Christine N.
    Prosser, Kathleen E.
    Stokes, Ryjul W.
    Cordes, Anna
    Metzler-Nolte, Nils
    Cohen, Seth M.
    CHEMICAL SCIENCE, 2020, 11 (05) : 1216 - 1225
  • [23] Using Insights From 3D Imaging of Organoids for Drug Discovery
    Badder, L.
    Borri, P.
    Moore, S. Maree J.
    Woolley, T.
    Marsh-Durban, V.
    Dale, T. C.
    JOURNAL OF PATHOLOGY, 2022, 256 : S3 - S3
  • [24] Modelling Nash for Drug Discovery Using 3D Liver Microtissues
    Kostadinova, Radina
    Strobel, Simon
    Rupp, Jana
    Steiert, Sabrina
    Guye, Patrick
    Messner, Simon
    HEPATOLOGY, 2018, 68 : 1010A - 1010A
  • [25] Progressing 3D spheroid analysis into a HTS drug discovery method
    Kessel, S.
    Sincoff, E.
    Dery, O.
    MOLECULAR BIOLOGY OF THE CELL, 2013, 24
  • [26] Advances in, and prospects of, 3D preclinical models for skin drug discovery
    Imran, Mohammad
    Moyle, Peter Michael
    Kamato, Danielle
    Mohammed, Yousuf
    DRUG DISCOVERY TODAY, 2024, 29 (12)
  • [27] Protein interactions in 3D: From interface evolution to drug discovery
    Winter, Christof
    Henschel, Andreas
    Tuukkanen, Anne
    Schroeder, Michael
    JOURNAL OF STRUCTURAL BIOLOGY, 2012, 179 (03) : 347 - 358
  • [28] High-throughput imaging: Focusing in on drug discovery in 3D
    Li, Linfeng
    Zhou, Qiong
    Voss, Ty C.
    Quick, Kevin L.
    LaBarbera, Daniel V.
    METHODS, 2016, 96 : 97 - 102
  • [30] Modeling the 3D structure of GPCRs: Advances and application to drug discovery
    Becker, OM
    Shacham, S
    Marantz, Y
    Noiman, S
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2003, 6 (03) : 353 - 361